Nuclear membrane receptors and channels as targets for drug development in cardiovascular diseases

Author： Bkaily Ghassan   Avedanian Levon   Jacques Danielle  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.87, Iss.2, 2009-02, pp. : 108-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen Receptors as Targets for Drug Development for Breast Cancer, Osteoporosis and Cardiovascular Diseases

By  

Current Cancer Drug Targets, Vol. 4, Iss. 6, 2004-09 ,pp. : 483-499

Bentham Science Publishers

Access to resources Recommend Favorite

Orphan Nuclear Receptors as Targets for Drug Development

By Mukherjee Subhajit   Mani Sridhar  

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1439-1468

Springer Publishing Company

Access to resources Recommend Favorite

MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases

By  

Current Drug Targets, Vol. 18, Iss. 4, 2017-02 ,pp. : 463-472

Bentham Science Publishers

Access to resources Recommend Favorite

The Nuclear Receptors FXR and LX alpha Potential Targets for the Development of Drugs Affecting Lipid Metabolism and Neoplastic Diseases

By  

Current Pharmaceutical Design, Vol. 7, Iss. 4, 2001-03 ,pp. : 231-259

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Matrix Metalloproteinases: Drug Targets in Cardiovascular Diseases)

By  

Current Drug Targets, Vol. 14, Iss. 3, 2013-03 ,pp. : 275-275

Bentham Science Publishers

Access to resources Recommend Favorite